DBV Technologies (DBVT) Research & Development (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Research & Development of $31.2 million for Q2 2026, down 7.42% year-on-year from $33.7 million in Q2 2025, and down 6.59% on a QoQ basis from $33.4 million in Q1 2026.

DBV Technologies (DBVT) Research & Development (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Research & Development for 7 consecutive years, with $31.2 million the latest figure, recorded in Q2 2026.

  • Quarterly Research & Development fell 7.42% year-over-year to $31.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $126.1 million (up 28.99% YoY) and the FY2025 annual result came in at $116.7 million, up 30.6% from the prior year.
  • Research & Development eased to $31.2 million in Q2 2026 per DBVT's latest filing, from $33.4 million in the prior quarter.
  • Over the last five years, Research & Development for DBVT reached as high as $33.7 million in Q2 2025 and fell as low as $12.2 million in Q1 2022.
  • A 5-year average of $22.6 million and a median of $21.5 million in 2024 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2022 — Research & Development surged 153.69% — and 2023, when it sank 56.86%.
  • Year by year, Research & Development stood at $29.6 million in 2022, then plunged by 56.86% to $12.8 million in 2023, then soared by 47.98% to $18.9 million in 2024, then soared by 73.99% to $32.9 million in 2025, then dropped by 5.14% to $31.2 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $31.2 million, $33.4 million, and $32.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -17.94 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 541.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -2.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.66 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.37 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 343.97 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 31.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 31.20 Mn
Mar 31, 2026 33.40 Mn
Dec 31, 2025 32.89 Mn
Sep 30, 2025 28.62 Mn
Jun 30, 2025 33.70 Mn
Mar 31, 2025 21.50 Mn
Dec 31, 2024 18.90 Mn
Sep 30, 2024 23.66 Mn
Jun 30, 2024 25.37 Mn
Mar 31, 2024 21.40 Mn
Dec 31, 2023 12.78 Mn
Sep 30, 2023 13.80 Mn
Jun 30, 2023 17.62 Mn
Mar 31, 2023 16.04 Mn
Dec 31, 2022 29.61 Mn
Sep 30, 2022 15.10 Mn
Jun 30, 2022 18.61 Mn
Mar 31, 2022 12.22 Mn
Dec 31, 2021 11.67 Mn
Sep 30, 2021 16.32 Mn